228 related articles for article (PubMed ID: 29901967)
41. Pharmacokinetics of ionized versus total magnesium in subjects with preterm labor and preeclampsia.
Taber EB; Tan L; Chao CR; Beall MH; Ross MG
Am J Obstet Gynecol; 2002 May; 186(5):1017-21. PubMed ID: 12015530
[TBL] [Abstract][Full Text] [Related]
42. [Magnesium sulphate for the management of preeclampsia].
Rozenberg P
Gynecol Obstet Fertil; 2006 Jan; 34(1):54-9. PubMed ID: 16406662
[TBL] [Abstract][Full Text] [Related]
43. A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia.
Belfort MA; Anthony J; Saade GR; Allen JC;
N Engl J Med; 2003 Jan; 348(4):304-11. PubMed ID: 12540643
[TBL] [Abstract][Full Text] [Related]
44. Randomized trial to compare acceptability of magnesium sulphate administration for preeclampsia and eclampsia: Springfusor pump versus standard of care.
Ononge S; Nakimuli A; Byamugisha J; Adroma M; Kiondo P; Easterling T; Bracken H
PLoS One; 2024; 19(6):e0286361. PubMed ID: 38865319
[TBL] [Abstract][Full Text] [Related]
45. Magnesium sulphate for prevention of eclampsia: are intramuscular and intravenous regimens equivalent? A population pharmacokinetic study.
Salinger DH; Mundle S; Regi A; Bracken H; Winikoff B; Vicini P; Easterling T
BJOG; 2013 Jun; 120(7):894-900. PubMed ID: 23530757
[TBL] [Abstract][Full Text] [Related]
46. Expectant management in severe preeclampsia: does magnesium sulfate prevent the development of eclampsia?
Chen FP; Chang SD; Chu KK
Acta Obstet Gynecol Scand; 1995 Mar; 74(3):181-5. PubMed ID: 7900522
[TBL] [Abstract][Full Text] [Related]
47. Loading dose of magnesium sulphate versus standard regime for prophylaxis of pre-eclampsia.
Shoaib T; Khan S; Javed I; Bhutta SZ
J Coll Physicians Surg Pak; 2009 Jan; 19(1):30-3. PubMed ID: 19149977
[TBL] [Abstract][Full Text] [Related]
48. Effects of magnesium sulfate infusion upon clotting parameters in patients with pre-eclampsia.
Assaley J; Baron JM; Cibils LA
J Perinat Med; 1998; 26(2):115-9. PubMed ID: 9650132
[TBL] [Abstract][Full Text] [Related]
49. Magnesium sulphate for the management of preeclampsia and eclampsia in low and middle income countries: a systematic review of tested dosing regimens.
Gordon R; Magee LA; Payne B; Firoz T; Sawchuck D; Tu D; Vidler M; de Silva D; von Dadelszen P
J Obstet Gynaecol Can; 2014 Feb; 36(2):154-163. PubMed ID: 24518915
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of a low-cost, low-power syringe pump to deliver magnesium sulfate intravenously to pre-eclamptic women in a Malawian referral hospital.
Skerrett E; Kommwa E; Maynard K; Juarez A; Mataya R; Richards-Kortum R; Oden ZM
BMC Pregnancy Childbirth; 2017 Jun; 17(1):191. PubMed ID: 28629437
[TBL] [Abstract][Full Text] [Related]
51. The use of magnesium sulfate for women with severe preeclampsia or eclampsia diagnosed during the postpartum period.
Vigil-De Gracia P; Ludmir J
J Matern Fetal Neonatal Med; 2015; 28(18):2207-9. PubMed ID: 25373431
[TBL] [Abstract][Full Text] [Related]
52. The relation between magnesium sulfate therapy and fetal heart rate variability.
Atkinson MW; Belfort MA; Saade GR; Moise KJ
Obstet Gynecol; 1994 Jun; 83(6):967-70. PubMed ID: 8190442
[TBL] [Abstract][Full Text] [Related]
53. [Effect of Magnesium Sulfate, Nifedipine Tablet Combined Salvia Injection on ET-1/NO, TXA2/PGI2 and Hemorheology of Preeclampsia Patients].
Zheng XY; Yao J; Zhu JM; Li M; Qiu SQ; Zhu ZX; Zhang M
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Aug; 35(8):962-5. PubMed ID: 26485911
[TBL] [Abstract][Full Text] [Related]
54. Therapy with both magnesium sulfate and nifedipine does not increase the risk of serious magnesium-related maternal side effects in women with preeclampsia.
Magee LA; Miremadi S; Li J; Cheng C; Ensom MH; Carleton B; Côté AM; von Dadelszen P
Am J Obstet Gynecol; 2005 Jul; 193(1):153-63. PubMed ID: 16021073
[TBL] [Abstract][Full Text] [Related]
55. Is magnesium sulfate for prevention or only therapeutic in preeclampsia?
Tannirandorn Y
J Med Assoc Thai; 2005 Jul; 88(7):1003-10. PubMed ID: 16241034
[TBL] [Abstract][Full Text] [Related]
56. Blood loss at cesarean delivery in women on magnesium sulfate for preeclampsia.
Graham NM; Gimovsky AC; Roman A; Berghella V
J Matern Fetal Neonatal Med; 2016; 29(11):1817-21. PubMed ID: 26135780
[TBL] [Abstract][Full Text] [Related]
57. Is there benefit to continue magnesium sulphate postpartum in women receiving magnesium sulphate before delivery? A randomised controlled study.
Vigil-DeGracia P; Ludmir J; Ng J; Reyes-Tejada O; Nova C; Beltré A; Yuen-Chon V; Collantes J; Turcios E; Lewis R; Cabrera S
BJOG; 2018 Sep; 125(10):1304-1311. PubMed ID: 29878650
[TBL] [Abstract][Full Text] [Related]
58. Assessment of serum magnesium levels and its outcome in neonates of eclamptic mothers treated with low-dose magnesium sulfate regimen.
Das M; Chaudhuri PR; Mondal BC; Mitra S; Bandyopadhyay D; Pramanik S
Indian J Pharmacol; 2015; 47(5):502-8. PubMed ID: 26600638
[TBL] [Abstract][Full Text] [Related]
59. Fetal ionized magnesium levels parallel maternal levels during magnesium sulfate therapy for preeclampsia.
Mason BA; Standley CA; Whitty JE; Cotton DB
Am J Obstet Gynecol; 1996 Jul; 175(1):213-7. PubMed ID: 8694054
[TBL] [Abstract][Full Text] [Related]
60. Postpartum seizure prophylaxis: using maternal clinical parameters to guide therapy.
Isler CM; Barrilleaux PS; Rinehart BK; Magann EF; Martin JN
Obstet Gynecol; 2003 Jan; 101(1):66-9. PubMed ID: 12517647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
